Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability

Figure 2

Cumulative % drug release from quetiapine fumarate SLNs in 0.1 N Hydrochloric acid.